Wednesday, 1 October 2008


As we have mentioned before, an ever increasing number of journalists now dare report the incestuous relationships between the pharmaceutical industry and different entities such as scientists, doctors as well as non-profits and charities.

In Britain, where the healthcare system is public like ours, many patients see their lives and well-being threatened when the NHS (National Health Service) refuses to cover their expensive treatments. Patients who find themselves in such situations often turn to charitable associations to help them plead their case.

What the article from The Independent linked below exposes, is that while many of these charitable entities loudly advocate for the patients who were refused by the NHS for the coverage of their treatments, they never bring up the issue of how prohibitively expensive these treatments can be. The investigative reporter attempted to throw some light as to why.

Please link to the article below to discover the portion of the funding of certain charitable organizations that comes from Big Pharma resulting in a severe conflict of interest between pharmaceutical interests and those advocating for the patients.

As stated in the article: ‘’Tim Kendall, director of research at the Royal College of Psychiatrists said the pharmaceutical industry reached into "every corner of the health service" in order to gain influence. ‘’

No comments: